RecallDepth
Class III Terminated

Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.

Company
Jubilant Cadista Pharmaceuticals, Inc.
Recall Initiated
May 26, 2020
Posted
June 3, 2020
Recall Number
D-1281-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,313,333 tablets
Firm Location
Salisbury, MD, United States

Reason for Recall

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

Distribution

TN

Lot / Code Info

Lot #s 19P0437 & 19P0438, Exp. 09/30/2021.

More recalls by Jubilant Cadista Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class III Drug recalls